loadpatents
name:-0.045715808868408
name:-0.025059938430786
name:-0.0018219947814941
INGHARDT; Tord Patent Filings

INGHARDT; Tord

Patent Applications and Registrations

Patent applications and USPTO patent grants for INGHARDT; Tord.The latest application filed is for "antibodies to ticagrelor and methods of use".

Company Profile
1.16.27
  • INGHARDT; Tord - SODERTALJE SE
  • Inghardt; Tord - Molndal SE
  • Inghardt; Tord - Frillesas SE
  • Inghardt, Tord - M?ouml;lndal SE
  • Inghardt; Tord - Frilles.ang.s SE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Antibodies To Ticagrelor And Methods Of Use
App 20210371546 - BUCHANAN; Andrew ;   et al.
2021-12-02
Antibodies to ticagrelor and methods of use
Grant 10,954,308 - Buchanan , et al. March 23, 2
2021-03-23
Antibodies to ticagrelor and methods of use
Grant 10,487,154 - Buchanan , et al. Nov
2019-11-26
Antibodies To Ticagrelor And Methods Of Use
App 20190077882 - Buchanan; Andrew ;   et al.
2019-03-14
Antibodies To Ticagrelor And Methods Of Use
App 20180319897 - BUCHANAN; Andrew ;   et al.
2018-11-08
Antibodies to ticagrelor and methods of use
Grant 9,982,061 - Buchanan , et al. May 29, 2
2018-05-29
Antibodies To Ticagrelor And Methods Of Use
App 20160130366 - BUCHANAN; ANDREW ;   et al.
2016-05-12
Mandelic acid derivatives and their use as thrombin inhibitors
Grant 7,803,954 - Inghardt September 28, 2
2010-09-28
Salts
Grant 7,763,597 - Ahlqvist , et al. July 27, 2
2010-07-27
Thienopyrimidine compounds and uses thereof
Grant 7,723,331 - Giordanetto , et al. May 25, 2
2010-05-25
New Mandelic Acid Derivatives And Their Use As Thrombin Inhibitors
App 20100087651 - INGHARDT; Tord ;   et al.
2010-04-08
Mandelic acid derivatives and their use as thrombin inhibitors
Grant 7,645,751 - Inghardt January 12, 2
2010-01-12
Heterocyclic Mchr1 Antagonists And Their Use In Therapy
App 20080306055 - Egner; Bryan ;   et al.
2008-12-11
N-Piperidine Derivatives as Ccr3 Modulators
App 20080300232 - Brickmann; Kay ;   et al.
2008-12-04
New Salts
App 20080269176 - Ahlqvist; Matti ;   et al.
2008-10-30
Therapeutic Agents
App 20080221107 - Giordanetto; Fabrizio ;   et al.
2008-09-11
Mandelic acid derivatives and their use as thrombin inhibitors
App 20080090800 - Inghardt; Tord ;   et al.
2008-04-17
Therapeutic Agents
App 20080051405 - Giordanetto; Fabrizio ;   et al.
2008-02-28
New amidino derivatives and their use as thrombin inhibitors
App 20070249578 - Inghardt; Tord ;   et al.
2007-10-25
Salts
Grant 7,273,858 - Ahlqvist , et al. September 25, 2
2007-09-25
New mandelic acid derivatives and their use as thrombin inhibitors
App 20070218136 - Inghardt; Tord ;   et al.
2007-09-20
New mandelic acid derivatives and their use as thrombin inhibitors
App 20070202174 - Inghardt; Tord ;   et al.
2007-08-30
Therapeutic agents I
App 20070185079 - Evertsson; Emma ;   et al.
2007-08-09
Therapeutic agents II
App 20070185119 - Evertsson; Emma ;   et al.
2007-08-09
Pyridin-2-one compounds useful as inhibitors of thrombin
App 20070161643 - Bayrakdarian; Malken ;   et al.
2007-07-12
Amidino derivatives and their use as thrombin inhibitors
Grant 7,241,757 - Inghardt , et al. July 10, 2
2007-07-10
5,6-Dihydropyrin-2-one compounds useful as inhibitors of thrombin
App 20070099962 - Berggren; Kristina ;   et al.
2007-05-03
Mandelic acid derivatives and their use as thrombin inhibitors
Grant 7,129,233 - Inghardt , et al. October 31, 2
2006-10-31
New 3-aryl propionic acid derivatives and analogs
App 20060173204 - Andersson; Kjell ;   et al.
2006-08-03
Mandelic acid derivatives and their use as thrombin inhibitors
Grant 7,056,907 - Inghardt , et al. June 6, 2
2006-06-06
Immediate release pharmaceutical formulation
App 20060014734 - Alami; Susanna Abrahmsen ;   et al.
2006-01-19
New salts
App 20050234035 - Ahlqvist, Matti ;   et al.
2005-10-20
Mandelic acid derivatives and their use as thrombin inhibitors
App 20040242492 - Inghardt, Tord ;   et al.
2004-12-02
New 3-aryl propionic acid derivatives and analogs
App 20040229949 - Andersson, Kjell ;   et al.
2004-11-18
New amidino derivatives and their use as thrombin inhibitors
App 20040186090 - Inghardt, Tord ;   et al.
2004-09-23
Amidino derivatives and their use as thrombin inhibitors
Grant 6,750,243 - Inghardt , et al. June 15, 2
2004-06-15
Thiochromane derivatives and their use as thrombin inhibitors
Grant 6,716,834 - Andersson , et al. April 6, 2
2004-04-06
Mandelic acid derivatives and their use as throbin inhibitors
App 20040019033 - Inghardt, Tord ;   et al.
2004-01-29
Thiochromane derivatives and their use as thrombin inhibitors
App 20030220317 - Andersson, Kjell ;   et al.
2003-11-27
3-aryl propionic acid derivatives and analogs
Grant 6,630,600 - Andersson , et al. October 7, 2
2003-10-07
Amidinobenzylamine derivatives and their use as thrombin inhibitors
Grant 6,599,894 - Inghardt , et al. July 29, 2
2003-07-29
Crytalline form of (s)-2 ethoxy -3-[4-(2-{4- methanesulfonyloxyphenyl} ethoxy)phenyl]propanoic acid
Grant 6,531,622 - Boije , et al. March 11, 2
2003-03-11
New amidino derivatives and their use as thormbin inhibitors
App 20020068730 - Inghardt, Tord ;   et al.
2002-06-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed